These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 26105843)

  • 1. Maternal circulating PlGF concentrations and placenta-related pregnancy complications: First results from the CoLab AngF Study.
    Staff AC; Burke Ó; Benton S; von Dadelszen P; Szafranski P; Zhang C; Buhimschi C; Cetin I; Figueras F; Holzman C; Hubel C; Laivuori H; McElrath T; Myers ; Ness R; Poston L; Ris-Stalpers C; Roberts J; Schistermann E; Steegers E; Timmermans S; van der Post JA; Villa PM; Williams D; Redman C
    Pregnancy Hypertens; 2013 Apr; 3(2):59. PubMed ID: 26105843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP086. The modern search for possible predictors of preeclampsia in the first trimester of pregnancy (preliminary study).
    Khodzhaeva ZS; Ivanets TY; Alexeeva ML; Kholin AM; Akatyeva AS; Vavina OV; Sukhikh GT
    Pregnancy Hypertens; 2012 Jul; 2(3):287. PubMed ID: 26105408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PP143. Relationship between mid-pregnancy placenta growth factor and hemodynamics in the mother, fetus, and uterus.
    Woelkers DA; Ghashghaei R; Klisser K; Archer T
    Pregnancy Hypertens; 2012 Jul; 2(3):317. PubMed ID: 26105464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms.
    Burke Ó; Benton S; Szafranski P; von Dadelszen P; Buhimschi SC; Cetin I; Chappell L; Figueras F; Galindo A; Herraiz I; Holzman C; Hubel C; Knudsen U; Kronborg C; Laivuori H; Lapaire O; McElrath T; Moertl M; Myers J; Ness RB; Oliveira L; Olson G; Poston L; Ris-Stalpers C; Roberts JM; Schalekamp-Timmermans S; Schlembach D; Steegers E; Stepan H; Tsatsaris V; van der Post JA; Verlohren S; Villa PM; Williams D; Zeisler H; Redman CW; Staff AC;
    Pregnancy Hypertens; 2016 Jan; 6(1):53-9. PubMed ID: 26955773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.
    Rana S; Hacker M; Merport A; Salahuddin S; Verlohren S; Perschel F; Karumanchi SA
    Pregnancy Hypertens; 2012 Jul; 2(3):273-4. PubMed ID: 26105382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OS004. A link between the complement system and angiogenic imbalance inpreeclampsia: ficolin-2 deficiency.
    Molvarec A; Halmos A; Szijártó J; Csuka D; Füst G; Prohászka Z; Rigó J
    Pregnancy Hypertens; 2012 Jul; 2(3):177. PubMed ID: 26105219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements.
    Schoofs K; Engels T; Pape J; Henrich W; Stepan H; Verlohren S
    Pregnancy Hypertens; 2012 Jul; 2(3):269. PubMed ID: 26105374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia.
    Moore AG; Young H; Keller JM; Ojo LR; Yan J; Simas TA; Maynard SE
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2651-7. PubMed ID: 22861812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OS087. Maternal characteristics, mean arterial pressure and PLGF in early prediction of preeclampsia.
    Kuc S; Koster MP; Franx A; Schielen PC; Visser GH
    Pregnancy Hypertens; 2012 Jul; 2(3):225-6. PubMed ID: 26105301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PP161. Association of maternal vitamin D and placenta growth factor with early-onset severe preeclampsia.
    Robinson C; Wagner C; Hollis B; Baatz J; Johnson D
    Pregnancy Hypertens; 2012 Jul; 2(3):326. PubMed ID: 26105482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PP116. Circulating PlGF can help predict preeclampsia and adverse outcome in patients with suspected preeclampsia or fetal growth restriction.
    Sibiude J; Dionne MD; Guibourdenche J; Le Ray C; Anselem O; Serreau R; Goffinet F; Tsatsaris V
    Pregnancy Hypertens; 2012 Jul; 2(3):302-3. PubMed ID: 26105438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].
    Stepan H; Jank A
    Z Geburtshilfe Neonatol; 2009 Jun; 213(3):101-5. PubMed ID: 19536710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP117. Measurement of sFlt-1 and PlGF for prediction of pregnancy associated diseases.
    Stubert J; Ullmann S; Bolz M; Bohlmann M; Külz T; Gerber B; Reimer T
    Pregnancy Hypertens; 2012 Jul; 2(3):303. PubMed ID: 26105439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP121. Expression of PlGF, sFlt, MTF-1, HO-1 and HIF-1 alpha mRNAs in preeclampsia placenta and effect of preeclampsia sera on their expression of choriocarcinoma cells.
    Maebayashi A; Yamamoto T; Azuma H; Kato E; Kuno S; Murase T; Chishima F
    Pregnancy Hypertens; 2012 Jul; 2(3):304-5. PubMed ID: 26105443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.
    McElrath TF; Lim KH; Pare E; Rich-Edwards J; Pucci D; Troisi R; Parry S
    Am J Obstet Gynecol; 2012 Nov; 207(5):407.e1-7. PubMed ID: 22981320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PP178. Antenatal sFlt1 and PlGF levels at 20-28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report.
    Jantarasaengaram S; Tansatit T; Samkhoompim N
    Pregnancy Hypertens; 2012 Jul; 2(3):337. PubMed ID: 26105499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OS085. Decreased maternal circulating PLGF is a significant predictor of length of pregnancy in women with hypertensive disorders of pregnancy.
    Gullai N; Stenczer B; Molvarec A; Veresh Z; Nagy B; Rigo J
    Pregnancy Hypertens; 2012 Jul; 2(3):224. PubMed ID: 26105299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OS061. Placental growth factor reduces blood pressure and proteinuria in experimental preeclampsia.
    Makris A; Yeung K; Farrell P; Heffernan S; Thompson J; Xu B; Woolcock J; Ogle R; Thadhani R; Karumanchi A; Hennessy A
    Pregnancy Hypertens; 2012 Jul; 2(3):210. PubMed ID: 26105275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.